Passionate Pioneers with Mike Biselli

This episode’s Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow’ Sustainability Campaign, and how you can get involved: CLICK HEREEpisode Overview: Too many independent practices are being sold not because they failed, but because they never had the systems to succeed on their own terms.Paul Vigario is tackling this reality as founder and CEO of SurfCT.For over 25 years, Paul has helped more than 12,000 practices generate over $36 billion in healthcare revenue by combining visionary brand development, intelligent technology, and intentional patient experience design.His work proves that private practices don't need to consolidate to compete. They need the opportunity and guidance to modernize.From transforming a $2 million endodontics office into a $20 million national brand to helping doctors build automated, scalable legacy practices, Paul brings a blueprint for what independent healthcare can become.Join us to discover how SurfCT is redefining what's possible for private practice owners ready to think boldly and build to endure. Let's go!Episode Highlights:Paul Vigario built SurfCT from a UConn dorm room idea into a firm serving 12,000 practices globally.Independent practices can scale without selling, as ONE ENDO grew from $2M to $20M without acquisition.Doctors often operate for insurance companies without realizing it, playing the wrong game entirely.Removing front desks and automating workflows creates frictionless, high-margin practices that scale beyond the owner.The future of private practice is polarized: massive success or corporate acquisition, with nothing in between.About our Guest:Paul Vigario is the founder and CEO of SurfCT, a leading authority in healthcare practice strategy, design, and technology for private healthcare practices, known for its integrated approach to improving and modernizing operations. Over the past 25 years, he has helped more than 12,000 practices worldwide generate more than $36 billion in healthcare revenue, redefining how providers automate, scale, and grow. Widely recognized as a visionary leader and pioneer in healthcare innovation, Mr. Vigario has spent his career advancing the integration of technology, brand, and patient experience in modern healthcare through clarity of vision, purposeful design, and systems that create freedom for providers.Links Supporting This Episode: SurfCT website: CLICK HEREPaul Vigario LinkedIn page: CLICK HERESurfCT LinkedIn page: CLICK HEREMike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website: CLICK HERESubscribe to newsletter: CLICK HEREGuest nomination form: CLICK HERE

This episode’s Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow’ Sustainability Campaign, and how you can get involved: CLICK HEREEpisode Overview: Healthcare's workforce crisis demands innovative solutions that transform how we develop and deploy talent.Our next guest, Van Ton-Quinlivan, is addressing this challenge as CEO of Futuro Health, building the nation's largest network of allied healthcare workers.With extensive experience spanning private, public, and nonprofit sectors, Van brings a unique perspective to workforce development shaped by her personal journey as a Vietnamese refugee who found opportunity through education. Now she's dedicated to unlocking that same potential for others.Recognized as one of the Top 50 Women Leaders in Healthcare and among the 100 Most Influential Higher Education Leaders, Van shares Futuro Health's pioneering approach to creating community-based education pipelines that serve both workers seeking meaningful careers and employers needing compassionate, skilled talent.Join us to discover how inclusive workforce development is transforming lives and strengthening healthcare communities nationwide. Let's go!Episode Highlights:Education as a gateway to opportunity - Van shares her personal journey as a Vietnamese refugee and how education transformed her life, fueling her passion to unlock opportunities for others through workforce developmentBuilding the largest allied health network - Futuro Health is creating community-based education and training pipelines to address the critical shortage of healthcare workers across the nationHuman Touch Healthcare program - A six-week signature program focused on emotional intelligence, cultural competence, and teamwork designed specifically for adult learners without traditional lecture formatsBalancing AI and human connection - As healthcare adopts AI, strengthening uniquely human skills like compassion becomes essential to distinguish when to use human agents versus AI agentsJPMorgan Chase Foundation partnership - Upcoming grant will enable 12 employers (providers, health plans, or rural networks) to implement the Futuro Health method for growing local healthcare workers from untapped communitiesAbout our Guest:Van Ton-Quinlivan is a nationally recognized workforce development leader with a career spanning the private, public, and nonprofit sectors. As CEO of Futuro Health, she’s building the nation’s largest network of allied healthcare workers. In 2022, she was appointed by Governor Newsom to help shape California’s healthcare workforce education and training.Van is the author and podcast host of WorkforceRx, promoting agile, multicultural solutions for employers, educators, and workers. Featured in major media and a sought-after keynote speaker, she’s been named one of the Top 50 Women Leaders in Healthcare (2024) and among the 100 Most Influential Higher Education Leaders (2025). She serves on several national boards and holds an MBA and MA in Education Policy from Stanford University.Born in Vietnam and raised in Hawaii, Van now lives in California. A new empty nester, she enjoys morning coffee walks with her husband, and recently took up taiko drumming.Links Supporting This Episode: Van Ton-Quinlivan LinkedIn page: CLICK HEREFuturo Health Website: CLICK HEREFuturo Health LinkedIn page: CLICK HEREMike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website: CLICK HERESubscribe to newsletter: CLICK HEREGuest nomination form: CLICK HERE

The best biotech and pharmaceutical innovations mean nothing if they can't be protected—and protected fast. Our next guest, Josh Goldberg, is solving this challenge as co-managing partner at Nath, Goldberg & Meyer, the #1 ranked patent law firm for biotech and pharmaceutical technologies. With nearly three decades of IP law experience and a unique background as a lab researcher, Josh brings an insider's understanding of how innovation actually happens. He's helped industry leaders like Amgen, Takeda, and GlaxoSmithKline turn breakthrough treatments into patent-protected portfolios—often in under a year instead of the typical four-year timeline. Driven by a passion for focus and strategic IP timing, Josh shares his pioneering approach to biotech and pharmaceutical patent prosecution. Join us to discover how smart IP strategy drives licensing power, regulatory success, and company valuation. Let's go!Episode Highlights:Focus drives success – Companies fail by trying to do everything at once; staying deliberate and focused is key to making real impactOne-year patent timelines vs. four years – Josh uses USPTO's Track 1 program to secure patents in record time, improving fundraising and M&A positioningClient-centered approach wins – Listening to unique client needs instead of one-size-fits-all strategies earned the firm its #1 rankingDiagnostic patents are back – New USPTO Director signals the patent office is "open for business" again after a decade of restrictionsScientist turned patent attorney – Josh's lab background gives him insider understanding of how innovation actually happensAbout our Guest: Joshua is the patent attorney innovation-driven pharmaceutical companies call when they need to turn complicated technologies into protected assets in record time.As co-managing partner at Nath, Goldberg & Meyer—the #1 ranked patent law firm for biotech and pharmaceutical technologies in both 2024 and 2025—Joshua leads IP efforts across industries like biotech, pharma, agriculture, renewable energy, and advanced materials. Whether it’s a blockbuster acne treatment like DUAC, a vitamin D analog lotion like Sorilux, OTC solutions like Salonpas and Germagic, or a leading drug used to reduce stomach acid and treat conditions like GERD, ulcers, and heartburn—like Protonix—Joshua helps turn high-stakes R&D into patent-protected portfolios, often in under a year instead of the typical four-year timeline.Though his climate and agricultre IP expertise has made him famous as the “green patent guy,” Joshua moves between disciplines skillfully and has helped industry leaders like Amgen, Takeda, Guilford Pharmaceuticals, Mayne, and Stiefel Laboratories (which was acquired by GlaxoSmithKline) build pharma portfolios that hold up under investor, acquirer, and FDA scrutiny.His journey didn’t begin in IP law, but in the lab, researching experimental pharmaceutical delivery systems. It gave him an edge most attorneys don’t have: understanding how innovation actually happens, and how to protect it without slowing a business down. Links Supporting This Episode: Nath, Goldberg & Meyer Website: CLICK HEREJoshua Goldberg LinkedIn page: CLICK HERENath, Goldberg & Meyer LinkedIn: CLICK HEREMike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website: CLICK HERESubscribe to newsletter: CLICK HEREGuest nomination form: CLICK HERE

Earwax affects over 35 million Americans and is the leading cause of conductive hearing loss- yet the procedure to remove it hasn't changed in 200 years. Our next guest, Sahil Diwan, is revolutionizing ear care as CEO of SafKan Health and creator of OtoSet®- the world's first FDA-cleared automated ear cleaning device. What began as a college dorm room experiment to solve his brother's chronic earwax problem has evolved into a viral phenomenon with over 250 million social media views and a network of clinics nationwide. Driven by a vision to become the "front door to ear and hearing care," Sahil shares how SafKan is using consumer-style virality to drive clinical adoption and create unprecedented access to care. Join us to discover how this first-generation immigrant is bridging medtech innovation with patient demand. Let's go!Episode Highlights:From Dorm Room to FDA Clearance: Started with 3D-printed prototypes in a college dorm to solve his brother's chronic earwax problem.Viral Social Media Strategy: Generated over 1 billion views in 18 months, using consumer virality to drive patient demand for a medical device.Rapid Clinic Expansion: Opening a new location every 2-3 weeks, aiming for 50 clinics by end of next year.Front Door to Ear Care: Creating accessible ear cleaning plus hearing screenings to identify hearing loss years earlier than traditional methods.Power of Mentorship: Finding experienced mentors, especially for FDA processes, saved significant time, stress, and money.About our Guest: Sahil Diwan is the Co-Founder and CEO of SafKan Health, the company behind OtoSet® — the world’s first automated ear-cleaning headphones that can clean earwax buildup in 30 seconds. FDA-cleared and used in clinics nationwide, OtoSet is transforming how earwax impaction — which affects 35M+ Americans and is a major cause of conductive hearing loss — is treated.A first-generation immigrant from India, Sahil’s journey began with a deeply personal problem — his brother Aadil's lifelong struggle with earwax buildup. What started as a college dorm experiment with 3D-printed prototypes is making ear care more accessible today — an example of how automating a common procedure can make patient care more efficient. Today, SafKan is taking on two of the biggest challenges in medtech commercialization — ensuring that clinic adoption leads to consistent product use, and fundraising for novel medical devices. SafKan is driving adoption by building awareness and patient demand through social media, with videos of OtoSet racking up 250M+ views, further increasing clinic utilization and patient outcomes. With $13M in venture funding, partnerships with leaders like GN ReSound, Sonova, and Starkey, and OtoSet being named among the Best Health Designs of 2023 by Fast Company — Sahil is writing the future of ear care by bridging the gap between medtech and patient access. Links Supporting This Episode: Safkan Health Website: CLICK HERESahil Diwan LinkedIn page: CLICK HERESafkan Health LinkedIn: CLICK HEREMike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website: CLICK HERESubscribe to newsletter: CLICK HEREGuest nomination form: CLICK HERE

This episode’s Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow’ Sustainability Campaign, and how you can get involved: CLICK HEREEpisode Overview: Specialty care shouldn't require months-long wait times or geographic limitations.Our next guest, AJ Patel, is revolutionizing this approach as CEO of TeleMed2U. With over 20 years of healthcare operations experience spanning drugstore chains and specialty pharmacy environments, AJ brings a unique perspective to virtual specialty care delivery. Having navigated TeleMed2U through significant growth and technological transformation over six years, he's built a network of 500+ providers across 20 specialties nationwide. Driven by a passion for breaking down geographic barriers and eliminating lengthy wait times, AJ shares how TeleMed2U is democratizing access to specialty care through innovative virtual solutions. Join us to discover how this technology-enabled platform is connecting patients with expert care regardless of location, transforming outcomes through collaborative medicine, and reshaping the future of specialty healthcare delivery. Let's go!Episode HighlightsProactive Healthcare Philosophy: Treat healthcare like car maintenance - invest in prevention to avoid downstream complications.Technology Pivot: After spending millions building their own tech stack, TeleMed2U pivoted to Advanced MD to focus on patient care.Geographic Solutions: Hub-and-spoke model uses providers across states, including Hawaii clinicians serving mainland patients.Collaborative Care: Seamless coordination between 20 specialties without patients navigating multiple healthcare systems.Future Vision: Measurement-based reimbursement, wearable tech integration, and shared diagnostic centers in rural areas.About our Guest: AJ Patel has more than 20 years of experience leading Healthcare Operations in the drugstore and specialty pharmacy environment. He currently serves as the Chief Executive Officer of TeleMed2U where he leads the company’s Sales & Operations, Recruiting, Legal and Credentialing/Contracting teams. He collaborates closely with the Advisory Board on the development of clinical programs and future strategy to enhance convenient access to specialty medical care in various markets across the country.Links Supporting This Episode: TeleMed2U Website: CLICK HEREAJ Patel LinkedIn page: CLICK HERETeleMed2U LinkedIn: CLICK HEREMike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website: CLICK HERESubscribe to newsletter: CLICK HEREGuest nomination form: CLICK HERE

This episode’s Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow’ Sustainability Campaign, and how you can get involved: CLICK HEREEpisode Overview: Healthcare organizations are drowning in data, yet struggling to unlock its potential to improve patient outcomes. Our next guest, Daniel Blumenthal, is transforming this challenge as VP of Strategy at MDClone. With nearly a decade pioneering synthetic data solutions, Daniel possesses a unique perspective bridging healthcare innovation and data privacy protection. From launching MDClone's North American operations to establishing partnerships with leading health systems like Intermountain Healthcare, he's witnessed firsthand how synthetic data can democratize healthcare insights while safeguarding patient privacy. Driven by a passion to turn data into actionable intelligence, Daniel shares MDClone's revolutionary vision to enable safe, collaborative discovery across healthcare ecosystems worldwide. Join us to discover how synthetic data is breaking down barriers, accelerating research, and empowering healthcare professionals to ask better questions of their data. Let's go!Episode Highlights:Building Trust in Healthcare Innovation: Healthcare innovations "live or die" based on whether people trust them, making trust-building as crucial as technology development.Synthetic Data Solves Privacy Challenge: MDClone generates "fake" patient data that protects privacy while maintaining statistical utility for research and analysis.$7 Million Savings at Intermountain: Synthetic data analysis of 100,000+ kidney disease patients helped optimize care interventions and deliver measurable ROI.AI Needs Patient Data Access: Generative AI could automate clinical processes, but requires patient data for training- making synthetic data essential for healthcare AI.Democratizing Healthcare Data: MDClone enables physicians, researchers, and administrators to access robust patient datasets previously blocked by privacy barriers.About our Guest: Daniel joined MDClone in its early days, launching the company’s operations in North America and establishing its first partnerships with healthcare organizations in the U.S. and Canada. With MDClone’s growth, Daniel now leads efforts to expand key partnerships and develop new software, services, and collaborations around the globe. Based in Chicago, Daniel has extensive experience building startup ecosystems and supporting entrepreneurs in the U.S. and Israel, having served as Deputy Consul for Economic Affairs at the Government of Israel Economic Mission in Chicago.Links Supporting This Episode: MDClone Website: CLICK HEREDaniel Blumenthal LinkedIn page: CLICK HEREMDClone LinkedIn: CLICK HEREMike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website: CLICK HERESubscribe to newsletter: CLICK HEREGuest nomination form: CLICK HERE

This episode’s Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow’ Sustainability Campaign, and how you can get involved: CLICK HEREEpisode Overview: The fight to save critically ill patients has remained largely unchanged for over 70 years- until now. Our next guest, Doug Evans, is revolutionizing critical care as President and CEO of Lungpacer Medical. With over three decades of medical device innovation and 300+ issued patents, Doug's personal mission was born from tragedy when his 14-year-old son required mechanical ventilation during his cancer battle. This heartbreaking experience drove Doug to tackle ventilator-induced diaphragm dysfunction, a condition that affects millions and contributes to the staggering 50% mortality rate among ventilated patients. Through groundbreaking neurostimulation technology, Doug and his team achieved the impossible—FDA approval for the first device designed to strengthen patients' diaphragms while on ventilation. Join us to discover how Lungpacer's pioneering AeroPace System is transforming outcomes, reducing ventilator dependency, and offering hope to families facing their darkest hours. Let's go!Episode Highlights:Personal Mission Born from Tragedy: Doug founded Lungpacer Medical after his 14-year-old son Cameron required mechanical ventilation during his cancer battle, driving his commitment to improve outcomes for critically ill patients.Historic FDA Breakthrough: In December 2024, Lungpacer's AeroPace System became the first and only FDA-approved device designed to strengthen the diaphragm in mechanically ventilated patients.Proven Clinical Results: The AeroPace System reduces ventilator time by 3 days, decreases 30-day ventilator dependency risk by 35%, and cuts re-ventilation risk by 60%.Life-Saving Patient Impact: Doug shared the powerful story of their first U.S. patient who had given up hope and wanted life support removed, but was saved through their technology and went home for the holidays.Next-Generation Innovation: The investigational AeroNova System promises continuous diaphragm stimulation with every breath, potentially improving not just muscle strength but also lung, brain, and heart function.About our Guest:Doug Evans brings over three decades of medical device innovation to his role as President and CEO of Lungpacer Medical Inc. As a serial entrepreneur and inventor, Doug has developed more than 3 00 issued patents covering pioneering devices that have revolutionized healthcare for over 15 million patients worldwide. Doug's journey with Lungpacer began with the heartbreaking experience of his 14-year-old son's struggle with mechanical ventilation during his cancer battle. After losing his son, Doug committed himself to solving the clinical challenges that affect millions of critically ill patients who depend on mechanical ventilation to survive. His determination has led to the development of revolutionary neurostimulation technology that works "like lifting weights to build strength" for patients' diaphragms while they remain on mechanical ventilation. This breakthrough approach addresses ventilator-induced diaphragm dysfunction, a major barrier to patient recovery that contributes to the staggering mortality rates in intensive care units. Doug's personal mission drives Lungpacer's vision: to free patients from prolonged mechanical ventilation and preserve their overall health during critical illness.BeforeLungpacer, Doug's career has spanned leadership roles across both public and private companies, where he has consistently created first-of-their-kind products. Hecurrently serves as Chairman at TELA Bio (NASDAQ: TELA) and sits on the board ofWhiteSwell Medical. His previous leadership includes roles as Operating Director andBoard Member of Intact Vascular, which Royal Philips acquired for $360 million in 2020,and Chief Operating Officer of Kensey Nash Corporation (NASDAQ: KNSY), acquired byRoyal DSM for $360 million in 2012.Doug holds a Bachelor's in Engineering Science, an honors degree in Bioengineering, and aMaster's in Business Management from Pennsylvania State University, plus a Master's inElectrical Engineering from the University of Pennsylvania.Beyond his professional achievements, Doug channels his personal experience in advocacy work as co-founder of the Cure4Cam Childhood Cancer Foundation, which raises awareness about childhood cancers and supports development of more humane therapies for children.Links Supporting This Episode: Lungpacer Medical Website: CLICK HEREDoug Evans LinkedIn page: CLICK HERELungpacer Medical LinkedIn page: CLICK HERELungpacer Medical Twitter page: CLICK HEREMike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website: CLICK HERESubscribe to newsletter: CLICK HEREGuest nomination form: CLICK HERE

This episode’s Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow’ Sustainability Campaign, and how you can get involved: CLICK HEREEpisode Overview: Healthcare equity isn't just a policy goal- it's a moral imperative that requires bold leadership and innovative solutions. Our next guest, Dr. Tyler Evans, embodies this mission as CEO and co-founder of Wellness Equity Alliance. With extensive experience on the front lines of global health crises, from Ebola outbreaks in sub-Saharan Africa to serving as New York City's first Chief Medical Officer during COVID-19, Tyler brings unparalleled expertise to vulnerable communities worldwide. His work spans refugees, LGBTQIA+ populations, indigenous communities, and those experiencing homelessness. Driven by a passion to bridge the gaps between public health and healthcare delivery, Tyler shares his transformative approach to building trusted community partnerships and addressing the intersection of pandemics, poverty, and politics. Join us to discover how the Wellness Equity Alliance is pioneering locally-nuanced healthcare access and why true health equity demands systemic change. Let's go!Episode Highlights:Personal Loss to Global Mission: Lost family by 21, driving dedication to vulnerable communities worldwide.NYC COVID Leadership: First Chief Medical Officer, administered 2+ million COVID vaccines.Four-Pillar Strategy: Partnerships, workforce development, data modernization, community trust.New Book Release: "Pandemics, Poverty, and Politics" examines pandemic drivers 1899-COVID.Breaking Silos: Integrating healthcare, government, education, and social services.About our Guest: Dr. Tyler Evans is an experienced and passionate infectious diseases and public health expert who has been on the front lines of major disease outbreaks (including two Ebola outbreaks) around the globe. Outside the U.S., he has mostly worked in sub-Saharan Africa, South Asia, and the Middle East with organizations like Doctors without Borders (Medecins Sans Frontieres) and Partners in Health. He is a tireless champion for medical humanitarianism and health equity, working with special populations across the world – including migrants (specifically refugees, asylees and victims of human trafficking), the LGBTQIA+ (with a special focus on transgender populations), people experiencing homelessness, people struggling with substance use, and indigenous communities.He was also the first Chief Medical Officer for New York City - leading the Office of Emergency Management’s (OEM) COVID-19 medical response. Dr. Evans is the CEO, chief medical officer and co-founder of Wellness and Equity Alliance, a national alliance of public health clinicians and supporting operations committed to transforming health care delivery to vulnerable communities with a focus on effective COVID-19 clinical services in strategic settings, and is an adjunct associate professor at University of Southern California (USC) Keck School of Medicine, Department of Population and Public Health Sciences.Links Supporting This Episode: Wellness Equity Alliance Website: CLICK HEREDr. Tyler Evans LinkedIn page: CLICK HEREDr. Tyler Evans Website: CLICK HEREMike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website: CLICK HERESubscribe to newsletter: CLICK HEREGuest nomination form: CLICK HERE